scPharmaceuticals Inc.

NasdaqGS SCPH

scPharmaceuticals Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2024: USD -70.56 M

scPharmaceuticals Inc. Free Cash Flow is USD -70.56 M for the Trailing 12 Months (TTM) ending September 30, 2024, a -26.15% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

scPharmaceuticals Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2023 was USD -55.93 M, a -87.26% change year over year.
scPharmaceuticals Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2022 was USD -29.87 M, a -2.14% change year over year.
scPharmaceuticals Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -29.24 M, a 12.31% change year over year.
scPharmaceuticals Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2020 was USD -33.35 M.

Key data

Date	Free Cash Flow	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities

NasdaqGS: SCPH

scPharmaceuticals Inc.

CEO	Mr. John H. Tucker
IPO Date	Nov. 17, 2017
Location	United States
Headquarters	2400 District Avenue
Employees	135
Sector	Health Care
Industries Pharmaceuticals

Description

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts.

Key trends

Past 5 years